Skip to main content
Erschienen in: Journal of Neurology 12/2006

01.12.2006 | ORIGINAL COMMUNICATION

The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura

verfasst von: Shahir Mazaheri, Mehrdad Hajilooi, Alireza Rafiei

Erschienen in: Journal of Neurology | Ausgabe 12/2006

Einloggen, um Zugang zu erhalten

Abstract

Migraine is considered to be a polygenic multifactorial disease with various environmental and genetic etiologies. Tumor necrosis factor-alpha (TNF-α), a potent immunomodulator and pro-inflammatory cytokine, has been implicated in many pathological processes in brain. The hypothesis of this study was that migraine without aura (MWA) might be associated with TNF-α (-308) polymorphism, resulting in increased TNF-α production. Genotyping was performed on DNA extracted from peripheral leukocytes by PCR–SSP method in 221 patients with WMA and 183 healthy control subjects from Iranian population. The results showed that the frequency of −308 A variant allele was higher in MWA than in the control group (40.6% versus 22.3%, OR 3.73, 95% CI 2.4–5.82, p < 0.0001). TNF-α GA heterozygous genotype, high producer, was significantly more prevalent in patients with MWA than controls (74% versus 44.7%, p < 0.0001) whilst the low producer GG homozygous genotype was less frequent in patients compared with controls (22.4% versus 55.3%, p < 0.0001). The logistic regression analysis showed a significant association for TNF-α (−308A) female allele carriers with MWA at reproductive ages (OR 2.56; 95% CI, 1.57–4.16, p < 0.0001) when compared with their matched control subjects.
In conclusion, this study demonstrates an association of tumor necrosis factor-alpha (-308A) carriage with MWA, suggesting that carrying a high responder TNF-alpha-308A allele may be a genetic factor in increasing the susceptibility to develop MWA.
Literatur
2.
Zurück zum Zitat Gallagher RM (2004) What do patients want from acute migraine treatment? Cephalalgia 24(Suppl)20:8–15PubMedCrossRef Gallagher RM (2004) What do patients want from acute migraine treatment? Cephalalgia 24(Suppl)20:8–15PubMedCrossRef
3.
Zurück zum Zitat Diamond M (2002) The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine: data from American Migraine Study II. Neurology 58(suppl 6): S3–S9PubMed Diamond M (2002) The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine: data from American Migraine Study II. Neurology 58(suppl 6): S3–S9PubMed
4.
Zurück zum Zitat Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF (2001) Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41:638–645PubMedCrossRef Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF (2001) Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41:638–645PubMedCrossRef
5.
Zurück zum Zitat Menken M, Munsat TL, Toole JF (2000) The global burden of disease study: implications for neurology. Arch Neurol 57:418–20PubMedCrossRef Menken M, Munsat TL, Toole JF (2000) The global burden of disease study: implications for neurology. Arch Neurol 57:418–20PubMedCrossRef
6.
Zurück zum Zitat Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964–82PubMed Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964–82PubMed
7.
Zurück zum Zitat Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH (1992) The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660–4PubMed Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH (1992) The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660–4PubMed
8.
Zurück zum Zitat Ferreira SH, Lorenzetti BB, Poole S (1993) Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol 110:1227–31PubMed Ferreira SH, Lorenzetti BB, Poole S (1993) Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol 110:1227–31PubMed
9.
Zurück zum Zitat Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF (1995) Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 692:244–50PubMedCrossRef Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF (1995) Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 692:244–50PubMedCrossRef
10.
Zurück zum Zitat Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ (1995) Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 7:1265–75 Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ (1995) Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 7:1265–75
11.
Zurück zum Zitat Sorkin LS, Xiao WH, Wagner R, Myers RR (1997) Tumor necrosis factor alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81:255–62PubMedCrossRef Sorkin LS, Xiao WH, Wagner R, Myers RR (1997) Tumor necrosis factor alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81:255–62PubMedCrossRef
12.
Zurück zum Zitat Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 121(3):417–24PubMedCrossRef Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 121(3):417–24PubMedCrossRef
13.
Zurück zum Zitat Covelli V, Munno I, Pellegrino NM, Altamura M, Decandia P, Marcuccio C, Di Venere A, Jirillo E (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurol (Napoli) 13(2):205–11 Covelli V, Munno I, Pellegrino NM, Altamura M, Decandia P, Marcuccio C, Di Venere A, Jirillo E (1991) Are TNF-alpha and IL-1 beta relevant in the pathogenesis of migraine without aura? Acta Neurol (Napoli) 13(2):205–11
14.
Zurück zum Zitat Covelli V, Munno I, Pellegrino NM, Di Venere A, Jirillo E, Buscaino GA (1990) Exaggerated spontaneous release of tumor necrosis factor-alpha/cachectin in patients with migraine without aura. Acta Neurol (Napoli) 12(4):257–63 Covelli V, Munno I, Pellegrino NM, Di Venere A, Jirillo E, Buscaino GA (1990) Exaggerated spontaneous release of tumor necrosis factor-alpha/cachectin in patients with migraine without aura. Acta Neurol (Napoli) 12(4):257–63
15.
Zurück zum Zitat Perini F, D’Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–31PubMedCrossRef Perini F, D’Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–31PubMedCrossRef
16.
Zurück zum Zitat Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T (1987) Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A 84(23):8535–9PubMedCrossRef Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T (1987) Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci U S A 84(23):8535–9PubMedCrossRef
17.
Zurück zum Zitat Beutler B, Cerami A (1986) Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320(6063):584–8PubMedCrossRef Beutler B, Cerami A (1986) Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320(6063):584–8PubMedCrossRef
18.
Zurück zum Zitat Wilson AG, di Giovine FS, Blakemore AI, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1(5):353PubMedCrossRef Wilson AG, di Giovine FS, Blakemore AI, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1(5):353PubMedCrossRef
19.
Zurück zum Zitat Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195–9PubMedCrossRef Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195–9PubMedCrossRef
20.
Zurück zum Zitat Hohjoh H, Nakayama T, Ohashi J, Miyagawa T, Tanaka H, Akaza T, Honda Y, Juji T, Tokunaga K (1999) Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 54:138–145PubMedCrossRef Hohjoh H, Nakayama T, Ohashi J, Miyagawa T, Tanaka H, Akaza T, Honda Y, Juji T, Tokunaga K (1999) Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 54:138–145PubMedCrossRef
22.
Zurück zum Zitat Miller SA, Dykes DD, Poleski HF (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215PubMedCrossRef Miller SA, Dykes DD, Poleski HF (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16:1215PubMedCrossRef
23.
Zurück zum Zitat Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS (1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43:456–63PubMedCrossRef Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS (1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43:456–63PubMedCrossRef
24.
Zurück zum Zitat Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV (1997) Cytokine gene polymorphism and heart transplant rejection. Transplantation 64: 776PubMedCrossRef Turner D, Grant SC, Yonan N, Sheldon S, Dyer PA, Sinnott PJ, Hutchinson IV (1997) Cytokine gene polymorphism and heart transplant rejection. Transplantation 64: 776PubMedCrossRef
25.
Zurück zum Zitat Hahn AB, Kasten-Jolly JC, Constantino DM, Graffunder E, Singh TP, Shen GK, Conti DJ (2001) TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation 72:660–5PubMedCrossRef Hahn AB, Kasten-Jolly JC, Constantino DM, Graffunder E, Singh TP, Shen GK, Conti DJ (2001) TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation 72:660–5PubMedCrossRef
26.
Zurück zum Zitat Trabace S, Brioli G, Lulli P, Morellini M, Giacovazzo M, Cicciarelli G, Martelletti P (2002) Tumor necrosis factor gene polymorphism in migraine. Headache 42:341–5PubMedCrossRef Trabace S, Brioli G, Lulli P, Morellini M, Giacovazzo M, Cicciarelli G, Martelletti P (2002) Tumor necrosis factor gene polymorphism in migraine. Headache 42:341–5PubMedCrossRef
27.
Zurück zum Zitat Rainero I, Grimaldi LM, Salani G, Valfre W, Rivoiro C, Savi L, Pinessi L (2004) Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine. Neurology 62(1):141–3PubMed Rainero I, Grimaldi LM, Salani G, Valfre W, Rivoiro C, Savi L, Pinessi L (2004) Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine. Neurology 62(1):141–3PubMed
28.
Zurück zum Zitat Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–7PubMedCrossRef Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2:560–7PubMedCrossRef
29.
Zurück zum Zitat Kemper RH, Meijler WJ, Korf J, Ter Horst GJ (2001) Migraine and function of the immune system: a metaanalysis of clinical literature published between 1966 and 1999. Cephalalgia 21:549–557PubMedCrossRef Kemper RH, Meijler WJ, Korf J, Ter Horst GJ (2001) Migraine and function of the immune system: a metaanalysis of clinical literature published between 1966 and 1999. Cephalalgia 21:549–557PubMedCrossRef
30.
Zurück zum Zitat Fargion S, Valenti L, Dongiovanni P, Fracanzani AL (2004) TNF alpha promoter polymorphisms. Methods Mol Med 98:47–58PubMed Fargion S, Valenti L, Dongiovanni P, Fracanzani AL (2004) TNF alpha promoter polymorphisms. Methods Mol Med 98:47–58PubMed
31.
Zurück zum Zitat McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP (2001) Association between polymorphism in regulatory region of gene encoding tumor necrosis factor alpha and risk of Alzheimer’s disease and vascular dementia: a case-control study. Lancet 357:436–439PubMedCrossRef McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP (2001) Association between polymorphism in regulatory region of gene encoding tumor necrosis factor alpha and risk of Alzheimer’s disease and vascular dementia: a case-control study. Lancet 357:436–439PubMedCrossRef
32.
Zurück zum Zitat Nadel S, Newport MJ, Booy R, Levin M (1996) Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174:878–80PubMed Nadel S, Newport MJ, Booy R, Levin M (1996) Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174:878–80PubMed
Metadaten
Titel
The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura
verfasst von
Shahir Mazaheri
Mehrdad Hajilooi
Alireza Rafiei
Publikationsdatum
01.12.2006
Erschienen in
Journal of Neurology / Ausgabe 12/2006
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-006-0270-4

Weitere Artikel der Ausgabe 12/2006

Journal of Neurology 12/2006 Zur Ausgabe

ORIGINAL COMMUNICATION

Reversible cerebral angiopathy

PIONEERS IN NEUROLOGY

Fridtjof Nansen (1861–1930)

ORIGINAL COMMUNICATION

Peduncular hallucinosis

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.